Hims & Hers Health announced yesterday afternoon an expansion into cardiovascular health. Through Heart Health by Hims, “providers will be able to personalize treatments to combine active ingredients found in clinically proven medications to address multiple conditions in one pill, demonstrating Hims & Hers’ rapidly advancing technology and pharmacy capabilities,” the company said in a statement. Hims & Hers also announced a strategic collaboration with the American College of Cardiology. The Heart Health by Hims approach uses clinical protocols that are based on principles of the ACC’s Atherosclerotic Cardiovascular Disease risk estimator. In addition, Heart Health by Hims customers will have access to cardiovascular health resources and education materials through CardioSmart.org, the patient engagement initiative of the ACC, the company said.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on HIMS:
- 3 Best Stocks to Buy Now, 8/1/2023, According to Top Analysts
- Block upgraded, Southwest downgraded: Wall Street’s top analyst calls
- Hims & Hers initiated with an Outperform at TD Cowen
- Hims & Hers down 4% at $8.31 after Strong Sell call from Spruce Point Capital
- Spruce Point calls Hims & Hers a ‘Strong Sell’, sees 25%-40% downside risk
